Copyright
©The Author(s) 2019.
World J Gastroenterol. Sep 28, 2019; 25(36): 5434-5450
Published online Sep 28, 2019. doi: 10.3748/wjg.v25.i36.5434
Published online Sep 28, 2019. doi: 10.3748/wjg.v25.i36.5434
Figure 7 Sirt1 inhibits Parp1 expression and acetylation in BNL CL2 cells.
A-D: Parp1 expression and acetylation in cells treated with H2O2 for different durarions or at different concentrations; E: The mRNA levels of Parp1 in Sirt1 knockdown cells treated with H2O2; F and G: Parp1 expression and acetylation in Sirt1 knockdown cells treated with H2O2; H and I: Parp1 expression and acetylation in cells treated with SRT1720, a Sirt1 activator. All data are presented as the mean ± SD. Statistical analysis was done by the Student’s t-test. aP < 0.05 vs 0 group or negative control, bP < 0.01 or negative control, dP < 0.01 vs H2O2 group, fP < 0.01 vs CLv group, jP < 0.05 vs shLv group, kP < 0.01 vs shLv group.
- Citation: Ye TJ, Lu YL, Yan XF, Hu XD, Wang XL. High mobility group box-1 release from H2O2-injured hepatocytes due to sirt1 functional inhibition. World J Gastroenterol 2019; 25(36): 5434-5450
- URL: https://www.wjgnet.com/1007-9327/full/v25/i36/5434.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i36.5434